Another Urgent ALERT: mRNA Booster Approved for Babies & Toddlers
December 15, 2022
Important Rally Information |
On Monday, December 4, 2022, Pfizer announced they were seeking Emergency Use Authorization (EUA) approval for their new mRNA based “bi-valent” covid/flu booster for children ages 6 months to 4 years old. By Friday, [Read More]